amiodarone has been researched along with Parkinson Disease, Secondary in 5 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Patients receiving amiodarone are at risk for the development of basal ganglia dysfunction which may persist if the drug is not discontinued or the dosage reduced." | 1.28 | Parkinsonism and amiodarone therapy. ( Olanow, CW; Werner, EG, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armon, C | 1 |
| Dotti, MT | 1 |
| Federico, A | 1 |
| Malaterre, HR | 1 |
| Renou, C | 1 |
| Kallee, K | 1 |
| Gauthier, A | 1 |
| Werner, EG | 1 |
| Olanow, CW | 1 |
| Lombard, M | 1 |
| Sarsfield, P | 1 |
| Keogh, JA | 1 |
5 other studies available for amiodarone and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Amiodarone for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Male; Parkinson Disease; Parkinson | 2007 |
Amiodarone-induced parkinsonism: a case report and pathogenetic discussion.
Topics: Amiodarone; Arrhythmias, Cardiac; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson | 1995 |
Akinesia and amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Liver Cirrhosis; Male; Middle Aged; | 1997 |
Parkinsonism and amiodarone therapy.
Topics: Aged; Amiodarone; Humans; Male; Parkinson Disease, Secondary | 1989 |
Adverse neurological response to amiodarone.
Topics: Aged; Amiodarone; Benzofurans; Humans; Male; Parkinson Disease, Secondary | 1986 |